Valuation: BioNote, Inc.

Market Cap 469B 345M 303M 286M 261M 488M 33.1B 492M 3.42B 1.33B 16.91B 1.3B 1.27B 54.34B P/E 2024
8.69x
P/E 2025 -6.32x
Enterprise Value 133B 97.67M 85.7M 80.94M 73.76M 138M 9.36B 139M 969M 375M 4.78B 367M 359M 15.37B EV / Sales 2024
0.77x
EV / Sales 2025 1.84x
Free-Float
12.48%
Yield 2024
4.25%
Yield 2025 -
1 day-0.54%
1 week-0.21%
Current month-2.62%
1 month-3.53%
3 months+4.62%
6 months-15.39%
Current year-15.08%
1 week 4,510
Extreme 4510
4,695
1 month 4,510
Extreme 4510
4,850
Current year 4,050
Extreme 4050
6,260
1 year 4,050
Extreme 4050
6,260
3 years 3,800
Extreme 3800
6,400
5 years 3,800
Extreme 3800
11,700
10 years 3,800
Extreme 3800
11,700
Manager TitleAgeSince
Chief Executive Officer 58 2020-07-31
Director of Finance/CFO 54 2021-03-31
Sales & Marketing 39 2025-03-25
Director TitleAgeSince
Chairman 65 2023-02-28
Director/Board Member 58 2020-07-31
Director/Board Member 50 -
Date Insider Type Main position Quantity % Market Cap. Importance
2/5/25 Free 10,000,000 9.8058%
2/5/25 Don

Chairman

10,000,000 9.8058%
4/14/24 Others 6,729,843 6.5991%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-0.21%-21.40%-1.48% 342M
+1.52%-7.16%+5.36%-83.73% 1.94B
-1.83%-0.07%-47.88%-60.46% 1.45B
-7.74%+20.69%-33.41% - 65.42M
Average -2.15%+3.61%-24.33%-48.56% 950.5M
Weighted average by Cap. -0.10%-2.72%-18.05%-67.15%

Financials

2024 2025
Net sales 103B 75.72M 66.44M 62.75M 57.18M 107M 7.26B 108M 751M 291M 3.71B 284M 278M 11.92B 118B 87.17M 76.49M 72.24M 65.83M 123M 8.35B 124M 864M 335M 4.27B 327M 320M 13.72B
Net income 55.26B 40.71M 35.72M 33.74M 30.75M 57.56M 3.9B 57.97M 404M 156M 1.99B 153M 150M 6.41B -87.5B -64.46M -56.56M -53.42M -48.68M -91.13M -6.18B -91.78M -639M -248M -3.16B -242M -237M -10.14B
Net Debt -401B -296M -260M -245M -223M -418M -28.35B -421M -2.93B -1.14B -14.48B -1.11B -1.09B -46.54B -336B -248M -217M -205M -187M -350M -23.73B -353M -2.46B -951M -12.13B -930M -910M -38.97B
Logo BioNote, Inc.
BioNote Inc is a Korea-based company principally engaged in the bio-contents business. The Company is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The Company is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
Employees
299
Date Price Change Volume
26-09-23 ₩4,645.00 -0.54% 43,275
26-09-22 ₩4,670.00 +0.43% 44,620
26-09-21 ₩4,650.00 -0.11% 28,398
26-09-18 ₩4,655.00 -1.27% 74,291
26-09-17 ₩4,715.00 +0.11% 50,336
  1. Stock Market
  2. Stocks
  3. A377740 Stock